---
layout: minimal-medicine
title: Zuclopenthixol
---

# Zuclopenthixol
### Generic Name
Zuclopenthixol

### Usage

Zuclopenthixol is an antipsychotic medication primarily used to treat schizophrenia and associated psychotic symptoms.  It's available in different formulations: tablets for both initial and maintenance treatment, and injections (acetate and decanoate) for acute and long-term management respectively.  The acetate injection is for short-term treatment of acute psychosis or exacerbations, while the decanoate injection provides longer-lasting effects for chronic management.  The choice of formulation depends on the individual's needs and the stage of their illness.

### Dosage

Dosage varies significantly depending on the formulation, the severity of the condition, and individual patient response.  Always follow the prescription instructions provided by your doctor.

**Adults (Schizophrenia-associated psychoses):**

* **Oral (tablets):**  Initial dose is typically 20-30 mg per day divided into smaller doses.  The maintenance dose might range from 20-50 mg daily, with a maximum of 150 mg per day.

* **Intramuscular (IM) Acetate Injection:** The initial dose is 50-150 mg. A maximum of four injections within two weeks (total 400 mg) is recommended. Subsequent doses may be given after 2-3 days as needed.  Transition to oral medication or decanoate injections usually follows.

* **Intramuscular (IM) Decanoate Injection:**  This is for long-term management.  A test dose of 100 mg is typically given initially to check for tolerance. Then, 200-500 mg is administered after at least one week, followed by repeat injections at 1-4-week intervals depending on response. The maximum weekly dose is 600 mg.  Injections greater than 2 mL should be split between two injection sites.

**Children:** The safety and efficacy of zuclopenthixol in children have not been established.

**Dosage Adjustments:**  No specific dosage adjustments are provided for hepatic or renal impairment in the manufacturer's labeling; however, caution is advised, and dose reduction may be necessary in hepatic impairment.

### Side Effects

**Common Side Effects:**

* Drowsiness
* Dizziness
* Dry mouth (xerostomia)
* Tremor
* Weakness
* Extrapyramidal symptoms (EPS) such as muscle stiffness, rigidity, restlessness (akathisia), and involuntary muscle movements (dystonia)
*  Constipation
* Nausea
* Weight gain

**Less Common but Serious Side Effects:**

* Neuroleptic malignant syndrome (NMS) – a rare but life-threatening condition characterized by high fever, muscle rigidity, altered mental status, and autonomic instability.
* Tardive dyskinesia (TD) – a potentially irreversible movement disorder characterized by involuntary movements of the face, mouth, and tongue.
* Orthostatic hypotension (a sudden drop in blood pressure upon standing)
* Agranulocytosis (a severe decrease in white blood cells)
* QT prolongation (abnormal heart rhythm)

If you experience any adverse effects, especially those listed above, contact your healthcare provider immediately.

### How it Works

Zuclopenthixol is a thioxanthene antipsychotic that works by blocking dopamine receptors in the brain. Dopamine is a neurotransmitter implicated in psychotic symptoms. By reducing dopamine activity, zuclopenthixol helps to alleviate hallucinations, delusions, and other psychotic symptoms associated with schizophrenia. It also affects serotonin and alpha-1 adrenergic receptors, which contributes to its overall effects.

### Precautions

* **Contraindications:** Zuclopenthixol is contraindicated in patients with hypersensitivity to the drug, acute alcohol or drug intoxication, CNS depression, coma, suspected or established subcortical brain damage, and circulatory collapse.
* **Interactions:**  Zuclopenthixol can interact with many other medications, including barbiturates, CNS depressants, antihypertensives,  metoclopramide, lithium, sibutramine, anticholinergic drugs, dopamine agonists, clozapine, and drugs that prolong the QT interval. Consult your doctor about any medications you are currently taking before starting zuclopenthixol.
* **Pregnancy and Breastfeeding:** Zuclopenthixol is a Category C drug during pregnancy. It is generally avoided unless the potential benefits outweigh the risks.  It's excreted in breast milk, making breastfeeding inadvisable during treatment.
* **Specific Populations:** Caution is advised in patients with cardiovascular disease, hepatic or renal impairment, seizures, gastrointestinal motility issues, Parkinson's disease, narrow-angle glaucoma,  or those at risk of falls.  Patients with prolactin-dependent tumors need careful monitoring.

### FAQs

* **Q: How long does it take for zuclopenthixol to work?**  A: The onset of effects varies depending on the formulation and individual response.  It may take several days or weeks to notice a significant improvement in symptoms.

* **Q: Can I stop taking zuclopenthixol suddenly?** A: No, abruptly stopping zuclopenthixol can lead to withdrawal symptoms.  Always follow your doctor's instructions for tapering off the medication.

* **Q: How should I store zuclopenthixol?** A: Store it as directed on the label, usually at room temperature, away from light and moisture.

* **Q: Is zuclopenthixol addictive?** A:  While physical dependence is not typically associated with zuclopenthixol, psychological dependence can occur in some cases.  It's important to follow your doctor's guidance.

* **Q: What should I do if I miss a dose?** A: Take the missed dose as soon as you remember, unless it's almost time for the next dose.  Do not double the dose.


**Disclaimer:** This information is intended for general knowledge and informational purposes only, and does not constitute medical advice.  Always consult with a healthcare professional for any health concerns or before making any decisions related to your health or treatment.  They can provide personalized guidance based on your individual medical history and needs.
